Compare · ELV vs LMRI
ELV vs LMRI
Side-by-side comparison of Elevance Health Inc. (ELV) and Lumexa Imaging Holdings Inc. (LMRI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ELV and LMRI operate in Medical Specialities (Health Care), so they compete in similar markets.
- ELV is the larger of the two at $80.92B, about 75.6x LMRI ($1.07B).
- Over the past year, ELV is up 35.0% and LMRI is down 39.7% - ELV leads by 74.7 points.
- ELV has been more active in the news (6 items in the past 4 weeks vs 1 for LMRI).
- ELV has more recent analyst coverage (23 ratings vs 9 for LMRI).
PerformanceELV+3.50%LMRI-39.71%
2025-12-11+0.00%2026-07-17
- Company
- Elevance Health Inc.
- Lumexa Imaging Holdings Inc.
- Price
- $372.94+0.02%
- $11.16+0.00%
- Market cap
- $80.92B
- $1.07B
- 1M return
- -6.26%
- +23.18%
- 1Y return
- +34.97%
- -39.71%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- 2025
- News (4w)
- 6
- 1
- Recent ratings
- 23
- 9
ELV
Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Latest ELV
- Director Peru Ramiro G bought $366,050 worth of shares (1,000 units at $366.05), increasing direct ownership by 10% to 10,908 units (SEC Form 4)
- President and CEO Boudreaux Gail bought $1,002,230 worth of shares (2,725 units at $367.79), increasing direct ownership by 2% to 171,976 units (SEC Form 4)
- SEC Form 10-Q filed by Elevance Health Inc.
- Elevance Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Elevance Health Reports Second Quarter 2026 Results; Raises Full-Year Guidance
- Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2026 Results on July 15, 2026
- New Elevance Health Public Policy Institute Study Examines Payment Disputes for Planned Procedures Under the No Surprises Act
- Thomas Carr Howe Middle School Unveils New Fitness and Strength Training Space Through Partnership with Elevance Health and Impact Fitness Foundation
- Elevance Health Makes Clinical Review Faster, More Connected with Health OS
- SEC Form 11-K filed by Elevance Health Inc.
Latest LMRI
- Lumexa Imaging Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation
- Director Mittl Robert Louis Jr. was granted 19,358 shares (SEC Form 4)
- Director Lungren Matthew was granted 19,358 shares (SEC Form 4)
- Director Karlin Bridget E was granted 19,358 shares (SEC Form 4)
- Director Joseph Molly was granted 19,358 shares, increasing direct ownership by 72% to 46,385 units (SEC Form 4)
- Director Eisenberg Glenn A was granted 19,358 shares (SEC Form 4)
- Director Cooper Henry Lee was granted 19,358 shares (SEC Form 4)
- Director Brodnax Brett was granted 19,358 shares, increasing direct ownership by 31% to 81,385 units (SEC Form 4)
- SEC Form 8-K filed by Lumexa Imaging Holdings Inc.
- Lumexa Imaging Announces Joint Venture with Hospital for Special Surgery (HSS) to Expand Advanced Outpatient Imaging in New York